E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4 Severity:T39
E7	Condition:T7 Name:T8
E9	Condition:T9 Name:T10
E11	Condition:T11 Name:T12 Severity:T50
E15	Condition:T15 Name:T16
E17	Condition:T17 Name:T18 Severity:T67 Stage:E41
E19	Condition:T19 Name:T20 Temporality:E29
E21	Condition:T21 Name:T22
E23	Condition:T23 Name:T24
E25	Condition:T25 Name:T26
E27	Condition:T27 Name:T28
E28	Eq-Comparison:T32 Operator:T29 Value:T31
E29	Eq-Comparison:T33 Temporal-Period:T34
E2	Modifier:T35 Modifies:T2
E4	Modifier:T36 Modifies:T2
E6	Or:T37 Arg:E4 Arg2:E2
E8	Study:T30
E10	Temporal-Connection:T38 Arg:E8 Arg2:E3
E12	Observation:T40 Name:T41 Eq-Comparison:E28
E14	Condition:T42 Name:T43 Severity:T47
E5	Modifier:T5 Modifies:T43
E16	Modifier:T6 Modifies:T43
E18	Modifier:T44 Modifies:T43
E20	Modifier:T45 Modifies:T43
E22	Or:T46 Arg:E16 Arg2:E5
E13	Modifier:T13 Modifies:T12
E24	Modifier:T14 Modifies:T12
E26	Modifier:T48 Modifies:T12
E30	Or:T49 Arg:E24 Arg2:E13
E31	Eq-Comparison:T51 Temporal-Period:T52
E32	Drug:T53 Name:T54
E33	Drug:T55 Name:T56 Temporality:E31
E34	Or:T57 Arg:E33 Arg2:E32
E35	Drug:T58 Name:T59
E36	Drug:T60 Name:T61
E37	Modifier:T62 Modifies:T61
E38	Modifier:T63 Modifies:T61
E39	Or:T64 Arg:E38 Arg2:E37
E40	Drug:T65 Name:T66
E41	Eq-Comparison:T68 Unit:T69 Value:T70
E42	Modifier:T71 Modifies:T20
E43	Modifier:T72 Modifies:T20
E44	Modifier:T73 Modifies:T20
E45	Or:T74 Arg:E43 Arg2:E44
E46	Eq-Comparison:T75 Temporal-Period:T76
E47	Procedure:T77 Temporality:E46
E48	Drug:T78 Name:T79
E49	Study:T80 Study-Of:E50
E50	Drug:T81
E51	Or:T82 Arg:E48 Arg2:E50
E52	Condition:T83 Name:T84
E53	Condition:T85 Name:T86
E54	Or:T87 Arg:E52 Arg2:E53
T1	Condition 55 65	depression
T2	Condition-Name 55 65	depression
T3	Condition 263 273	depression
T4	Condition-Name 263 273	depression
T7	Condition 488 510	neurological disorders
T8	Condition-Name 488 510	neurological disorders
T9	Condition 527 545	cognitive disorder
T10	Condition-Name 527 545	cognitive disorder
T11	Condition 580 588	diseases
T12	Condition-Name 580 588	diseases
T15	Condition 865 894	obsessive-compulsive disorder
T16	Condition-Name 865 894	obsessive-compulsive disorder
T17	Condition 795 816	psychiatric disorders
T18	Condition-Name 795 816	psychiatric disorders
T19	Condition 927 936	addiction
T20	Condition-Name 927 936	addiction
T21	Condition 834 847	schizophrenia
T22	Condition-Name 834 847	schizophrenia
T23	Condition 849 857	dementia
T24	Condition-Name 849 857	dementia
T25	Condition 859 863	ADHD
T26	Condition-Name 859 863	ADHD
T27	Condition 1093 1107	breast feeding
T28	Condition-Name 1093 1107	breast feeding
T29	Eq-Operator 305 306	≥
T31	Eq-Value 307 309	22
T32	Eq-Comparison 305 309	≥ 22
T33	Eq-Comparison 896 903	current
T34	Eq-Temporal-Period 896 903	current
T35	Modifier 47 54	bipolar
T36	Modifier 39 42	uni
T37	Or 44 46	or
T30	Study 184 189	study
T38	Temporal-Connection 152 163	At the time
T39	Severity 256 262	severe
T40	Observation 317 351	Montgomery-Åsberg Depression Scale
T41	Observation-Name 317 351	Montgomery-Åsberg Depression Scale
T42	Condition 445 458	comorbidities
T43	Condition-Name 445 458	comorbidities
T5	Modifier 432 444	neurological
T6	Modifier 419 428	endocrine
T44	Modifier 408 417	rheumatic
T45	Modifier 399 406	somatic
T46	Or 429 431	or
T47	Severity 392 398	severe
T13	Modifier 572 579	cardiac
T14	Modifier 561 567	kidney
T48	Modifier 554 559	liver
T49	Or 568 571	and
T50	Severity 547 553	severe
T51	Eq-Comparison 613 626	being treated
T52	Eq-Temporal-Period 613 626	being treated
T53	Drug 665 688	immunosuppressive drugs
T54	Drug-Name 665 688	immunosuppressive drugs
T55	Drug 644 661	anti-inflammatory
T56	Drug-Name 644 661	anti-inflammatory
T57	Or 662 664	or
T58	Drug 695 710	corticosteroids
T59	Drug-Name 695 710	corticosteroids
T60	Drug 727 740	a(nta)gonists
T61	Drug-Name 727 740	a(nta)gonists
T62	Modifier 722 726	beta
T63	Modifier 714 719	alpha
T64	Or 720 721	/
T65	Drug 742 766	immuno suppressant drugs
T66	Drug-Name 742 766	immuno suppressant drugs
T67	Severity 788 794	severe
T68	Eq-Comparison 818 824	Axis I
T69	Eq-Unit 818 822	Axis
T70	Eq-Value 823 824	I
T71	Modifier 904 911	alcohol
T72	Modifier 913 918	drugs
T73	Modifier 922 926	drug
T74	Or 919 921	or
T75	Eq-Comparison 961 968	already
T76	Eq-Temporal-Period 961 968	already
T77	Procedure 974 981	treated
T78	Drug 1002 1012	sertraline
T79	Drug-Name 1002 1012	sertraline
T80	Study 1058 1063	study
T81	Drug 1021 1042	alternate medications
T82	Or 1013 1016	and
T83	Condition 1070 1078	Pregnant
T84	Condition-Name 1070 1078	Pregnant
T85	Condition 1082 1091	lactating
T86	Condition-Name 1082 1091	lactating
T87	Or 1079 1081	or
T88	Life-Stage-And-Gender 1109 1114	women
A1	Eq-Operator-Value T29 GTEQ
A2	Eq-Temporal-Period-Value T34 present
A3	Temporal-Connection-Type-Value E10 during
A4	Severity-Value T39 severe
A5	Observation-Type-Value T41 clinical-score
A6	Severity-Value T47 severe
A7	Severity-Value T50 severe
A8	Eq-Temporal-Period-Value T52 present
A9	Severity-Value T67 severe
A10	Eq-Temporal-Period-Value T76 past
A11	Life-Stage-And-Gender-Type T88 female
R1	Equivalent-To Arg1:E12 Arg2:E3
R2	Caused-By Arg1:E7 Arg2:E9
R3	Example-Of Arg1:E35 Arg2:E32
R4	Example-Of Arg1:E36 Arg2:E32
R5	Example-Of Arg1:E40 Arg2:E32
R6	Example-Of Arg1:E21 Arg2:E17
R7	Example-Of Arg1:E23 Arg2:E17
R8	Example-Of Arg1:E25 Arg2:E17
R9	Example-Of Arg1:E15 Arg2:E17
R10	Using Arg1:E47 Arg2:E48
R11	Using Arg1:E47 Arg2:E50
R12	Equivalent-To Arg1:E27 Arg2:E53
R13	If-Then Arg1:T88 Arg2:E27